Salux Overview

  • Founded
  • 2002
  • Status
  • Private
  • Employees
  • 44
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 1

Salux General Information


Developer of a health management software designed to improve health through the use of technology. The company's software delivers clinical intelligence, flexibility, performance, safety features, up-to-date management and control indicators, enabling healthcare institutions to have access to management and support decision-making and accreditation processes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Medical Records Systems
Business/Productivity Software
Primary Office
  • Rua Furriel Luiz Antônio de Vargas, 380
  • Bela Vista
  • Porto Alegre, 90470-130
  • Brazil
+55 (51) 00000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Salux Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 01-Jan-2017 Completed Generating Revenue
To view Salux’s complete valuation and funding history, request access »

Salux Executive Team (1)

Name Title Board Seat Contact Info
Fabricio Avini Founder, Chief Executive Officer & Director
To view Salux’s complete executive team members history, request access »

Salux Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Salux Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CVentures Venture Capital Minority 000 0000 000000 0
To view Salux’s complete investors history, request access »